Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
169 USD | +3.48% | +0.41% | -6.33% |
05-02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
05-01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.14% | 9.13B | |
-4.63% | 182B | |
+2.62% | 111B | |
-2.43% | 68.48B | |
+1.31% | 49.69B | |
+8.53% | 44.46B | |
+2.33% | 40.67B | |
+21.29% | 31.22B | |
+2.58% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- UBS Adjusts Repligen Price Target to $170 From $210, Maintains Buy Rating